Integration of Neoadjuvant Systemic Therapy into Surgical Practice
In breast cancer, the use of postoperative, or adjuvant, chemotherapy is inextricably linked to the improved outcomes seen over the past several decades. Neoadjuvant chemotherapy has become the standard of care for patients with locally advanced breast cancer and has rapidly come to the forefront among potential treatments for patients with earlier-stage operable disease. Several studies have shown that breast cancer patients treated with neoadjuvant chemotherapy do not necessarily survive longer than those treated with conventional postoperative adjuvant chemotherapy; however, the use of neoadjuvant chemotherapy has several proven and theoretical advantages. This chapter reviews the potential merits of neoadjuvant therapy as it applies to breast cancer care in general, and breast surgery in particular.
KeywordsBreast Cancer Advanced Breast Cancer Axillary Dissection Breast Conservation Therapy Ipsilateral Breast Tumor Recurrence
- 5.Haagensen CD, Stout A. Carcinoma of the breast. II. Criteria of operability. Ann Surg. 1943;20108:859.Google Scholar
- 10.Jacquillat C, Weil M, Baillet F, et al. Results of neoadjuvant chemotherapy and radiation therapy in the breast-conserving treatment of 250 patients with all stages of infiltrative breast cancer. Cancer. 1990;66:20109–29.Google Scholar
- 15.Esserman L, Hylton N, Yassa L, Barclay J, et al. Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging. J Clin Oncol. 1999;17:20100–9.Google Scholar
- 24.Buzdar AU, Valero V, Ibrahim NK, et al. Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: an update of the initial randomized study population and data of additional patients treated with the same regimen. Clin Cancer Res. 2007;13(1):228–33.PubMedCrossRefGoogle Scholar
- 26.Boughey JC, Peintinger F, Meric-Bernstam F, Perry AC, Hunt KK, Babiera GV, et al. Impact of preoperative versus postoperative chemotherapy on the extent and number of surgical procedures in patients treated in randomized clinical trials for breast cancer. Ann Surg. 2006;244(3):464–70.PubMedGoogle Scholar